Sudhakar Jinka
Uppal Road
Hyderabad, TG 500007, India
Hyderabad, TG 500007, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Progesterone-Cationic Lipid Conjugate-Based Self-Aggregates for Cancer Cell-Selective Uptake through Macropinocytosis and the Antitumour Effect.
Journal: Molecular pharmaceutics
Published: May 03, 2023
Modification of α-Tocopherol Succinate with a Tumor-targeting Peptide Conjugate Enhances the Antitumor Efficacy of a Paclitaxel-loaded Lipid Aggregate.
Journal: Chemistry, an Asian journal
Published: November 09, 2022
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery.
Journal: Nanomedicine (London, England)
Published: March 26, 2021
Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
Journal: Biomedical materials (Bristol, England)
Published: January 12, 2021
Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.
Journal: Molecular pharmaceutics
Published: December 29, 2020
Methoxy-enriched cationic stilbenes as anticancer therapeutics.
Journal: Bioorganic chemistry
Published: December 31, 2019
In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles.
Journal: Biomaterials science
Published: January 03, 2019
Novel Amphiphilic G-Quadruplex Binding Synthetic Derivative of TMPyP4 and Its Effect on Cancer Cell Proliferation and Apoptosis Induction.
Journal: Biochemistry
Published: October 30, 2018
Phenazine-1-carboxamide functionalized mesoporous silica nanoparticles as antimicrobial coatings on silicone urethral catheters.
Journal: Scientific reports
Published: June 01, 2018
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.
Journal: Molecular pharmaceutics
Published: May 18, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026